Open AccessDecision on Chemotherapy Amidst COVID-19 Pandemic: a Review and a Practical Approach from Iran
Author(s) -
Afshin Rakhsha,
Samira Azghandi,
Farzad TaghizadehHesary
Publication year - 2020
Publication title -
infection and chemotherapy/gam'yeom gwa hwahag yo'beob/infection and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.724
H-Index - 26
eISSN - 2092-6448
pISSN - 1598-8112
DOI - 10.3947/ic.2020.52.4.496
Subject(s) - pandemic , medicine , covid-19 , intensive care medicine , disease , health care , infectious disease (medical specialty) , virology , pathology , economic growth , outbreak , economics
To provide a step-by-step approach to chemotherapy (CTx) in the novel coronavirus disease 2019 (COVID-19) era. The COVID-19 pandemic is the current global issue resulting in vast health implications. Amid the COVID-19 era, special attention must be paid to at-risk groups, including patients with cancer. To our knowledge, there is a paucity of data on the decision for CTx during the pandemic. We herein provide practical recommendations on the CTx of cancer patients over the pandemic based on our experience in an educational hospital. The decision on CTx should be considered to be individualized based on clinical findings. We hope that our experience provides a practical guide for clinical oncologists to deliver more effective cancer care over the COVID-19 pandemic.